Evidence-Based Hypertrophy & Hormonal Optimization Protocol
Research-backed | All sources cited
Research-backed | All sources cited
- Best program = Push/Pull/Legs 6x/week, 10–20 sets per muscle, 6–12 rep range, progressive overload every session. Compound lifts drive the most hormonal response.
- Sleep 8–9 hrs, eat 1.6–2.2 g protein/kg BW, keep dietary fat at ≥20–25% of total calories for maximal endogenous testosterone.
- Natural T stack: Vitamin D3 (5,000 IU) + Zinc (30 mg) + Ashwagandha KSM-66 (600 mg) + Tongkat Ali (400 mg) + Boron (10 mg) + Magnesium Glycinate (400 mg).
- Beginner AAS: Testosterone Enanthate 400–500 mg/wk for 12–16 weeks + Anastrozole 0.25 mg EOD as AI. Run PCT with Nolvadex 40/40/20/20 mg/day starting 2 weeks after last pin.
- Top peptides: BPC-157 (injury/recovery), TB-500 (systemic healing), CJC-1295 + Ipamorelin (GH optimization), MK-677 (oral GH secretagogue, no injections).
- Peer-reviewed before/after: natty lifters gain 2–4 kg LBM in 12–16 weeks. AAS-assisted (600 mg/wk Test): +6.1 kg LBM in same timeframe (Bhasin et al., NEJM 1996).
Optimal Resistance Training Protocol for Maximal Hypertrophy
The scientific literature is unambiguous: mechanical tension is the primary driver of muscle hypertrophy, followed by metabolic stress and muscle damage (Schoenfeld, 2010). The program below synthesizes current meta-analytical evidence on volume, frequency, intensity, and exercise selection.
Core Principles — Evidence-Based
Push / Pull / Legs — 6-Day Split
Day structure: Mon = Push A | Tue = Pull A | Wed = Legs A | Thu = Push B | Fri = Pull B | Sat = Legs B | Sun = Rest
Deload every 6–8 weeks — reduce volume by 40% for 1 week to facilitate supercompensation.
This structure trains each muscle group twice per week, optimizing the muscle protein synthesis (MPS) window (~48–72h recovery). Total weekly volume per muscle = 12–18 working sets.
— PUSH A & B (Chest · Shoulders · Triceps) —
— PULL A & B (Back · Biceps · Rear Delts) —
— LEGS A & B (Quads · Hamstrings · Glutes · Calves) —
Why Compound Movements Are Non-Negotiable
Heavy compound lifts — squat, deadlift, bench, OHP, pull-ups — recruit the largest cross-sectional muscle mass simultaneously and produce the most significant acute hormonal response. Kraemer & Ratamess (2005) documented that multi-joint exercises with high loads (≥85% 1RM) combined with short rest intervals maximally elevate serum testosterone, GH, and IGF-1 post-exercise. These anabolic hormones potentiate protein synthesis and satellite cell recruitment even in natural lifters.
Nutrition (Non-Negotiable)
The scientific literature is unambiguous: mechanical tension is the primary driver of muscle hypertrophy, followed by metabolic stress and muscle damage (Schoenfeld, 2010). The program below synthesizes current meta-analytical evidence on volume, frequency, intensity, and exercise selection.
Core Principles — Evidence-Based
| Variable | Optimal Range | Evidence |
| Weekly Sets / Muscle | 10–20 sets | Schoenfeld et al. (2017): >10 sets/wk superior to lower volumes for hypertrophy |
| Rep Range | 6–30 reps | Morton et al. (2016): load ranges 30–85% 1RM produce similar hypertrophy if taken to near-failure |
| Training Frequency | 2× / muscle / week | Schoenfeld et al. (2016): 2× per week superior to 1× for hypertrophy at equal volume |
| Proximity to Failure | 0–3 RIR | Effort is the key equalizer — stop 0–3 reps in reserve for maximal stimulus |
| Rest Intervals | 2–5 minutes | Schoenfeld et al. (2016): 3 min rest produces superior hypertrophy vs. 1 min |
| Progression | Weekly overload | Progressive overload is mandatory — add load, reps, or sets each week |
Push / Pull / Legs — 6-Day Split
Day structure: Mon = Push A | Tue = Pull A | Wed = Legs A | Thu = Push B | Fri = Pull B | Sat = Legs B | Sun = Rest
Deload every 6–8 weeks — reduce volume by 40% for 1 week to facilitate supercompensation.
This structure trains each muscle group twice per week, optimizing the muscle protein synthesis (MPS) window (~48–72h recovery). Total weekly volume per muscle = 12–18 working sets.
— PUSH A & B (Chest · Shoulders · Triceps) —
- Barbell Bench Press — 4 × 6–8
- Incline DB Press — 3 × 10–12
- Overhead Press (BB or DB) — 4 × 6–10
- Lateral Raises — 4 × 15–20
- Cable or DB Flyes — 3 × 12–15
- Tricep Pushdowns — 3 × 12–15
- Overhead Tricep Extension — 3 × 12–15
— PULL A & B (Back · Biceps · Rear Delts) —
- Weighted Pull-Ups — 4 × 5–8
- Barbell or T-Bar Row — 4 × 6–10
- Chest-Supported Row — 3 × 10–12
- Cable Pullover — 3 × 12–15
- Rear Delt Fly — 4 × 15–20
- EZ-Bar Curl — 3 × 10–12
- Incline DB Curl — 3 × 12–15
— LEGS A & B (Quads · Hamstrings · Glutes · Calves) —
- Back Squat — 4 × 5–8
- Romanian Deadlift — 4 × 8–10
- Leg Press — 3 × 12–15
- Lying Leg Curl — 4 × 10–12
- Hip Thrust — 3 × 10–15
- Standing Calf Raise — 4 × 12–20
Why Compound Movements Are Non-Negotiable
Heavy compound lifts — squat, deadlift, bench, OHP, pull-ups — recruit the largest cross-sectional muscle mass simultaneously and produce the most significant acute hormonal response. Kraemer & Ratamess (2005) documented that multi-joint exercises with high loads (≥85% 1RM) combined with short rest intervals maximally elevate serum testosterone, GH, and IGF-1 post-exercise. These anabolic hormones potentiate protein synthesis and satellite cell recruitment even in natural lifters.
Nutrition (Non-Negotiable)
| Macro | Target | Rationale |
| Protein | 1.6–2.2 g/kg BW/day | Morton et al. (2018) meta-analysis: ~1.62 g/kg is the MPS saturation threshold |
| Carbohydrates | 4–7 g/kg BW/day | Primary fuel for resistance training; replenishes glycogen; anti-catabolic |
| Dietary Fat | ≥20–25% of total kcal | Testosterone is synthesized from cholesterol. Fat below 20% = significantly lower T (Hamalainen et al., 1984) |
| Caloric Surplus | +300–500 kcal/day | Lean bulk approach. Excessive surplus accelerates fat gain without proportional additional muscle |
Hormonal Optimization: The Anabolic Cascade
Muscle hypertrophy is fundamentally a hormonal phenomenon. The primary anabolic hormones — testosterone, IGF-1, and growth hormone — govern protein synthesis rates, satellite cell activation, nitrogen retention, and anti-catabolic signaling.
The HPG Axis (How Your Body Makes Testosterone)
Endogenous testosterone is governed by the Hypothalamic-Pituitary-Gonadal (HPG) axis: hypothalamus releases GnRH in pulses → pituitary releases LH and FSH → Leydig cells in the testes produce testosterone. This negative feedback loop is the target of both natural optimization AND exogenous AAS use — which suppresses LH/FSH via negative feedback, causing testicular atrophy, which is why PCT is required post-cycle to restore it.
Muscle hypertrophy is fundamentally a hormonal phenomenon. The primary anabolic hormones — testosterone, IGF-1, and growth hormone — govern protein synthesis rates, satellite cell activation, nitrogen retention, and anti-catabolic signaling.
| Hormone | Primary Function | Key Stimulus | Optimal Range (Males) |
| Testosterone | MPS ↑, satellite cell activation, anti-catabolism | Heavy compounds, sleep, dietary fat, low stress | 600–900 ng/dL (natty upper) |
| IGF-1 | Muscle fiber hypertrophy, mTOR activation, hyperplasia | GH pulsatility, dietary protein, resistance training | 150–350 ng/mL |
| Growth Hormone | Lipolysis, IGF-1 production, connective tissue repair | Sleep (SWS phase), fasting, high-intensity exercise | 0.4–10 ng/mL (pulsatile) |
| Cortisol | CATABOLIC — muscle protein breakdown, inhibits T synthesis | Chronic stress, overtraining, sleep deprivation | MINIMIZE chronically elevated levels |
| Estradiol (E2) | Libido, bone density, anabolic synergist in males | Aromatization of testosterone (especially in fat tissue) | 20–40 pg/mL (on cycle: up to 60) |
The HPG Axis (How Your Body Makes Testosterone)
Endogenous testosterone is governed by the Hypothalamic-Pituitary-Gonadal (HPG) axis: hypothalamus releases GnRH in pulses → pituitary releases LH and FSH → Leydig cells in the testes produce testosterone. This negative feedback loop is the target of both natural optimization AND exogenous AAS use — which suppresses LH/FSH via negative feedback, causing testicular atrophy, which is why PCT is required post-cycle to restore it.
Evidence-Based Natural Enhancement Stack
The following interventions are supported by peer-reviewed clinical research demonstrating statistically significant effects on serum testosterone in men. Not broscience — published, replicated data.
Lifestyle Factors (Highest Impact — Do These First)
Supplementation Stack
Vitamin D3 + K2 — 5,000 IU D3 + 100 mcg K2 · Daily
Pilz et al. (2011): 12-month supplementation ↑ testosterone by ~25% in deficient men. Vitamin D receptor (VDR) is expressed directly in Leydig cells. K2 directs calcium metabolism and prevents soft tissue calcification.
Zinc — 25–40 mg elemental · Daily
Prasad et al. (1996): zinc-deficient men who supplemented ↑ T by nearly 2× over 6 months. Zinc is a cofactor in testosterone synthesis and 5α-reductase pathway regulation.
Ashwagandha KSM-66 — 300–600 mg extract · Daily
Wankhede et al. (2015) RCT: 8-week supplementation ↑ testosterone by 15–17% and ↓ cortisol by 27% vs. placebo. Mechanism: reduces HPG-axis suppression via cortisol modulation.
Tongkat Ali (Eurycoma longifolia) — 200–400 mg standardized · Daily
Tambi et al. (2012): supplementation ↑ free testosterone by 37% and improved sperm quality. Mechanism: inhibition of SHBG binding + stimulation of Leydig cells via quassinoid compounds.
Boron — 6–10 mg · Daily
Naghii et al. (2011): 10 mg/day boron for 1 week ↑ free testosterone by 29.5% and ↓ SHBG. Boron reduces estrogen-driven SHBG synthesis in the liver, freeing bound testosterone.
Magnesium Glycinate — 300–400 mg · Nightly
Cinar et al. (2011): magnesium supplementation in athletes ↑ testosterone by 24% after 4 weeks. Magnesium competes with SHBG for testosterone binding sites, increasing the free T fraction.
Fadogia Agrestis — 400–600 mg · Daily
Yakubu et al. (2005) animal data: demonstrates LH-mimicking activity at Leydig cells → ↑ testosterone synthesis. Human RCT data is currently limited — used empirically in performance communities. Promising but not yet definitively proven in humans.
Creatine Monohydrate — 5 g · Daily (no loading required)
Van der Merwe et al. (2009): creatine ↑ DHT by ~56% after 7 days in rugby players. Creatine increases 5α-reductase substrate availability, increasing conversion of testosterone → DHT (more androgenically potent).
The following interventions are supported by peer-reviewed clinical research demonstrating statistically significant effects on serum testosterone in men. Not broscience — published, replicated data.
Lifestyle Factors (Highest Impact — Do These First)
| Factor | Effect on Testosterone | Evidence |
| Sleep 7–9 hrs | ↑ 10–15% per additional hour (up to 9h) | Leproult & Van Cauter (2011): 5 hrs sleep reduced daytime T by 10–15% in young men. 70% of GH secretion is sleep-dependent. |
| Body Fat 10–15% | ↑ Significantly — adipose aromatizes T→E2 | Loves et al. (2008): each BMI unit decrease → +2–3% T. Excess fat = excess aromatase = HPG axis suppression. |
| Resistance Training | Acute ↑ 20–40 min post-exercise; chronic ↑ baseline | Kraemer & Ratamess (2005): compound lifts ≥85% 1RM produce maximal acute T response. |
| Stress Reduction | ↑ T inversely proportional to cortisol | Cumming et al. (1983): cortisol directly suppresses Leydig cell function — T and cortisol are functionally antagonistic. |
| Alcohol Avoidance | Even 2–3 drinks/day lowers T ~6.8% | Välimäki et al. (1990): acute ethanol ingestion directly inhibits testicular T synthesis within hours. |
Supplementation Stack
Vitamin D3 + K2 — 5,000 IU D3 + 100 mcg K2 · Daily
Pilz et al. (2011): 12-month supplementation ↑ testosterone by ~25% in deficient men. Vitamin D receptor (VDR) is expressed directly in Leydig cells. K2 directs calcium metabolism and prevents soft tissue calcification.
Zinc — 25–40 mg elemental · Daily
Prasad et al. (1996): zinc-deficient men who supplemented ↑ T by nearly 2× over 6 months. Zinc is a cofactor in testosterone synthesis and 5α-reductase pathway regulation.
Ashwagandha KSM-66 — 300–600 mg extract · Daily
Wankhede et al. (2015) RCT: 8-week supplementation ↑ testosterone by 15–17% and ↓ cortisol by 27% vs. placebo. Mechanism: reduces HPG-axis suppression via cortisol modulation.
Tongkat Ali (Eurycoma longifolia) — 200–400 mg standardized · Daily
Tambi et al. (2012): supplementation ↑ free testosterone by 37% and improved sperm quality. Mechanism: inhibition of SHBG binding + stimulation of Leydig cells via quassinoid compounds.
Boron — 6–10 mg · Daily
Naghii et al. (2011): 10 mg/day boron for 1 week ↑ free testosterone by 29.5% and ↓ SHBG. Boron reduces estrogen-driven SHBG synthesis in the liver, freeing bound testosterone.
Magnesium Glycinate — 300–400 mg · Nightly
Cinar et al. (2011): magnesium supplementation in athletes ↑ testosterone by 24% after 4 weeks. Magnesium competes with SHBG for testosterone binding sites, increasing the free T fraction.
Fadogia Agrestis — 400–600 mg · Daily
Yakubu et al. (2005) animal data: demonstrates LH-mimicking activity at Leydig cells → ↑ testosterone synthesis. Human RCT data is currently limited — used empirically in performance communities. Promising but not yet definitively proven in humans.
Creatine Monohydrate — 5 g · Daily (no loading required)
Van der Merwe et al. (2009): creatine ↑ DHT by ~56% after 7 days in rugby players. Creatine increases 5α-reductase substrate availability, increasing conversion of testosterone → DHT (more androgenically potent).
Expected Natural Ceiling: Fully optimized natural testosterone in a healthy young male = 700–1,050 ng/dL (top of reference range). Most untrained males sit at 400–600 ng/dL. The above lifestyle + supplementation stack can realistically push totals 20–35% above individual baseline in deficient/suboptimal individuals. Genetic ceiling for natural T is fixed — no supplement overrides this.
Anabolic-Androgenic Steroid Usage: Detailed Cycle Guide
Exogenous AAS administration supraphysiologically elevates androgen receptor (AR) occupancy, dramatically increasing nitrogen retention, muscle protein synthesis rates, satellite cell proliferation, and IGF-1 secretion beyond what is physiologically achievable naturally. Bhasin et al. (1996) demonstrated in a landmark NEJM RCT that exogenous testosterone at 600 mg/week produced 6.1 kg greater LBM gain vs. placebo — even the no-exercise + testosterone group outgained the exercise-only + placebo group.
Ester Selection & Pharmacokinetics
CYCLE 01 — BEGINNER: Test Only
The first cycle should always be testosterone only. This establishes your baseline response, identifies individual AI needs, and provides the cleanest data for future cycles. Running multiple compounds on a first cycle makes it impossible to attribute effects (positive or negative) to any specific compound.
Timeline: [Wk 1–16: Test E + AI] → [Wk 17: Bridge/clear] → [Wk 18–21: PCT] → [Wk 22+: Off until fully recovered]
Bloodwork protocol: Get pre-cycle (true baseline), mid-cycle (week 8), and post-PCT bloodwork.
Monitor: Total T, Free T, E2 (sensitive assay), LH, FSH, CBC, lipid panel, liver enzymes (ALT/AST), hematocrit.
CYCLE 02 — INTERMEDIATE: Test + Oral
After at least one successful test-only cycle and full recovery confirmed by bloodwork, a second compound can be introduced. Anavar (Oxandrolone) is the most beginner-friendly oral add-on — low androgenicity, minimal liver stress at moderate doses, and notable strength and lean mass benefits.
CYCLE 03 — ADVANCED: Test + Deca + Dbol Kickstart
The classic "Golden Era" mass cycle. Dianabol kickstart (weeks 1–6 while Deca/Test builds to stable blood levels) with Test + Deca as the base. Historically responsible for the majority of elite physiques in the 1970s–80s. Requires experienced bloodwork management and understanding of prolactin/progesterone management.
Exogenous AAS administration supraphysiologically elevates androgen receptor (AR) occupancy, dramatically increasing nitrogen retention, muscle protein synthesis rates, satellite cell proliferation, and IGF-1 secretion beyond what is physiologically achievable naturally. Bhasin et al. (1996) demonstrated in a landmark NEJM RCT that exogenous testosterone at 600 mg/week produced 6.1 kg greater LBM gain vs. placebo — even the no-exercise + testosterone group outgained the exercise-only + placebo group.
Ester Selection & Pharmacokinetics
| Ester | Half-Life | Injection Frequency | Typical Use |
| Testosterone Propionate | ~2 days | EOD (every other day) | Cutting, faster blood level stabilization |
| Testosterone Enanthate | ~5–6 days | 2× per week (e.g. Mon/Thu) | Bulking — most common beginner ester. Recommend this for first cycle. |
| Testosterone Cypionate | ~7–8 days | 1–2× per week | TRT and bulking; nearly identical to Enanthate |
| Nandrolone Decanoate (Deca) | ~14 days | Once per week | Intermediate stack; joint lubrication, serious mass |
| Trenbolone Acetate | ~1–2 days | EOD | Advanced only — 5× androgenic potency of testosterone |
| Oxandrolone (Anavar) | ~9 hrs (oral) | Daily (split AM/PM) | Strength, lean gains, most common first oral add-on |
| Stanozolol (Winstrol) | ~9 hrs (oral) | Daily | Cutting, vascularity, hardening effect |
CYCLE 01 — BEGINNER: Test Only
The first cycle should always be testosterone only. This establishes your baseline response, identifies individual AI needs, and provides the cleanest data for future cycles. Running multiple compounds on a first cycle makes it impossible to attribute effects (positive or negative) to any specific compound.
| Week | Compound | Dose | Frequency / Notes |
| 1–16 | Testosterone Enanthate | 400–500 mg/wk | 2× weekly — e.g. 200–250 mg Monday + 200–250 mg Thursday |
| 1–16 | Anastrozole (AI) | 0.25 mg EOD | Adjust based on bloodwork. Target E2 = 25–35 pg/mL. Do NOT run AI without bloodwork — low E2 is as bad as high E2. |
| 18–21 | Nolvadex (Tamoxifen) — PCT | 40/40/20/20 mg/day | Start 2 weeks after last injection (allows ester to clear). 4-week PCT to restore HPG axis. |
| 18–21 | Clomid (optional add-on) | 25/25/12.5/12.5 mg/day | Stack with Nolvadex for more aggressive LH/FSH recovery. Optional but recommended for first cycle. |
Timeline: [Wk 1–16: Test E + AI] → [Wk 17: Bridge/clear] → [Wk 18–21: PCT] → [Wk 22+: Off until fully recovered]
Bloodwork protocol: Get pre-cycle (true baseline), mid-cycle (week 8), and post-PCT bloodwork.
Monitor: Total T, Free T, E2 (sensitive assay), LH, FSH, CBC, lipid panel, liver enzymes (ALT/AST), hematocrit.
CYCLE 02 — INTERMEDIATE: Test + Oral
After at least one successful test-only cycle and full recovery confirmed by bloodwork, a second compound can be introduced. Anavar (Oxandrolone) is the most beginner-friendly oral add-on — low androgenicity, minimal liver stress at moderate doses, and notable strength and lean mass benefits.
| Week | Compound | Dose | Notes |
| 1–16 | Testosterone Enanthate | 500 mg/wk | Same protocol as Cycle 01. Backbone compound. |
| 1–12 | Oxandrolone (Anavar) | 40–60 mg/day | Split AM/PM dose. Add TUDCA 500 mg/day for liver support (hepatoprotection). |
| 1–16 | Anastrozole | 0.25–0.5 mg EOD | May need slight dose increase vs. Cycle 01. Always dose based on bloodwork. |
| 18–21 | Nolvadex — PCT | 40/40/20/20 mg/day | Same standard PCT protocol. |
CYCLE 03 — ADVANCED: Test + Deca + Dbol Kickstart
The classic "Golden Era" mass cycle. Dianabol kickstart (weeks 1–6 while Deca/Test builds to stable blood levels) with Test + Deca as the base. Historically responsible for the majority of elite physiques in the 1970s–80s. Requires experienced bloodwork management and understanding of prolactin/progesterone management.
| Week | Compound | Dose | Notes |
| 1–16 | Testosterone Enanthate | 500–600 mg/wk | Anchor compound. Always run Test as base. |
| 1–16 | Nandrolone Decanoate (Deca) | 300–400 mg/wk | Run Test:Deca ratio ≥ 2:1 to manage prolactin/progesterone. Add Cabergoline 0.25 mg 2×/wk. |
| 1–6 | Dianabol (kickstart) | 30–50 mg/day | Rapid blood saturation while injectables build. TUDCA 500 mg/day mandatory. Do not run longer than 6 weeks. |
| 1–16 | Anastrozole | 0.5 mg EOD | Higher dose needed for elevated total androgen load. Monitor E2 closely. |
| 18–22 | Nolvadex + Clomid — PCT | 40/40/20/20 + 50/50/25/25 | Extended 5-week PCT due to Deca's long half-life. Nandrolone suppresses the HPG axis for longer than Test. |
Pre-Cycle Checklist (mandatory before ANY AAS use):
1. Bloodwork baseline — Total T, LH, FSH, E2, lipids, CBC, liver enzymes, PSA (if 30+)
2. Minimum 2 years of consistent natural training — anabolic potential of AAS is largely wasted without pre-existing training adaptation
3. Body fat ≤ 15% — elevated adiposity increases aromatization and estrogen-related complications
4. All ancillaries sourced BEFORE first pin — AI (Anastrozole/Exemestane), PCT drugs (Nolvadex/Clomid), liver support (TUDCA)
5. Never start a cycle you're not prepared to finish and PCT from
Peptides for Muscle Growth, GH Optimization & Recovery
Peptides are short amino acid chains that act on specific receptor systems. Unlike AAS, most peptides work by stimulating endogenous secretion rather than replacing it — meaning they generally preserve HPG/GH axis function. Key targets: GHRH receptors, GH secretagogue receptors (GHSR), angiogenesis, and tissue repair.
CJC-1295 (with DAC) — 1–2 mg · Once per week (subcutaneous)
GHRH analogue with Drug Affinity Complex for extended half-life (~8 days). Produces sustained GH pulse amplification. Best combined with a GHRP (like Ipamorelin) for synergistic GH release. Chronically elevates IGF-1.
Ipamorelin — 200–300 mcg · 2–3× daily (subcutaneous, pre-sleep dose is priority)
Selective GH secretagogue (GHSR agonist). Highly specific — does not significantly raise cortisol or prolactin unlike older GHRPs (GHRP-2, GHRP-6). Stack with CJC-1295 for ~5–10× GH pulse amplification vs. baseline. Most popular GH peptide combination currently.
BPC-157 — 250–500 mcg · 1–2× daily (subcutaneous, near injury site)
Body Protection Compound. Promotes angiogenesis, collagen synthesis, and tendon-bone healing. Dramatically accelerates recovery from musculoskeletal injuries. Strong evidence in animal models; used extensively in athletic communities empirically for injury recovery.
TB-500 (Thymosin β4) — 2–2.5 mg · 2× per week (subcutaneous)
Promotes actin upregulation, systemic angiogenesis, and wound healing. Highly synergistic with BPC-157 for injury protocols — run them together. Longer half-life allows less frequent dosing vs. BPC-157.
MK-677 (Ibutamoren) — 12.5–25 mg · Daily (ORAL — no injections)
Oral GH secretagogue (non-peptide GHSR agonist). Significantly elevates GH pulsatility and IGF-1 chronically. Chapman et al. (1996) demonstrated IGF-1 increases of ~52% vs. placebo in young adults. Notable benefit: oral administration, no injections required. Common effects: water retention, increased appetite, vivid dreams (GH-related). Best run at night due to appetite stimulation and sleep benefit.
IGF-1 LR3 — 20–60 mcg · Post-workout (subcutaneous or intramuscular)
Long-arginine extension analogue of IGF-1 with 60–70× longer half-life than native IGF-1. Acts directly on muscle IGF-1 receptors, driving satellite cell activation and myogenic differentiation. High anabolic potential — often used in intermediate/advanced protocols or post-AAS-cycle during recovery when the GH axis is restoring.
Recommended Stacks:
GH Optimization Stack: CJC-1295 DAC (2 mg, once weekly) + Ipamorelin (200 mcg, 3× daily). Synergistic GHRH + GHSR activation, maximizing GH pulse amplitude and duration. Expect IGF-1 increases of 30–60% within 4–8 weeks.
Injury Recovery Stack: BPC-157 (500 mcg near injury site, 1–2× daily) + TB-500 (2 mg, twice weekly systemically). Run 4–8 weeks on active injuries, or preventatively during high-volume training blocks.
Peptides are short amino acid chains that act on specific receptor systems. Unlike AAS, most peptides work by stimulating endogenous secretion rather than replacing it — meaning they generally preserve HPG/GH axis function. Key targets: GHRH receptors, GH secretagogue receptors (GHSR), angiogenesis, and tissue repair.
CJC-1295 (with DAC) — 1–2 mg · Once per week (subcutaneous)
GHRH analogue with Drug Affinity Complex for extended half-life (~8 days). Produces sustained GH pulse amplification. Best combined with a GHRP (like Ipamorelin) for synergistic GH release. Chronically elevates IGF-1.
Ipamorelin — 200–300 mcg · 2–3× daily (subcutaneous, pre-sleep dose is priority)
Selective GH secretagogue (GHSR agonist). Highly specific — does not significantly raise cortisol or prolactin unlike older GHRPs (GHRP-2, GHRP-6). Stack with CJC-1295 for ~5–10× GH pulse amplification vs. baseline. Most popular GH peptide combination currently.
BPC-157 — 250–500 mcg · 1–2× daily (subcutaneous, near injury site)
Body Protection Compound. Promotes angiogenesis, collagen synthesis, and tendon-bone healing. Dramatically accelerates recovery from musculoskeletal injuries. Strong evidence in animal models; used extensively in athletic communities empirically for injury recovery.
TB-500 (Thymosin β4) — 2–2.5 mg · 2× per week (subcutaneous)
Promotes actin upregulation, systemic angiogenesis, and wound healing. Highly synergistic with BPC-157 for injury protocols — run them together. Longer half-life allows less frequent dosing vs. BPC-157.
MK-677 (Ibutamoren) — 12.5–25 mg · Daily (ORAL — no injections)
Oral GH secretagogue (non-peptide GHSR agonist). Significantly elevates GH pulsatility and IGF-1 chronically. Chapman et al. (1996) demonstrated IGF-1 increases of ~52% vs. placebo in young adults. Notable benefit: oral administration, no injections required. Common effects: water retention, increased appetite, vivid dreams (GH-related). Best run at night due to appetite stimulation and sleep benefit.
IGF-1 LR3 — 20–60 mcg · Post-workout (subcutaneous or intramuscular)
Long-arginine extension analogue of IGF-1 with 60–70× longer half-life than native IGF-1. Acts directly on muscle IGF-1 receptors, driving satellite cell activation and myogenic differentiation. High anabolic potential — often used in intermediate/advanced protocols or post-AAS-cycle during recovery when the GH axis is restoring.
Recommended Stacks:
GH Optimization Stack: CJC-1295 DAC (2 mg, once weekly) + Ipamorelin (200 mcg, 3× daily). Synergistic GHRH + GHSR activation, maximizing GH pulse amplitude and duration. Expect IGF-1 increases of 30–60% within 4–8 weeks.
Injury Recovery Stack: BPC-157 (500 mcg near injury site, 1–2× daily) + TB-500 (2 mg, twice weekly systemically). Run 4–8 weeks on active injuries, or preventatively during high-volume training blocks.
The following data is sourced directly from peer-reviewed clinical trials and meta-analyses — not anecdotal forum posts. These represent documented outcomes under controlled conditions.
Natural Training — 12–16 Weeks (Resistance Training Naïve Men)
Sources: Schoenfeld et al. (2017) meta-analysis; Kraemer et al. (1999) hormonal responses to 12 weeks RT in healthy males.
AAS-Assisted — Testosterone 600 mg/week × 10–16 Weeks (Bhasin et al., NEJM 1996 RCT)
Notable: Even the no-exercise + testosterone group (+3.2 kg LBM) outgained the exercise-only + placebo group (+1.9 kg LBM). The exercise + testosterone group gained +6.1 kg.
MK-677 Oral GH Secretagogue — 12 Months (Nass et al., 2008 RCT)
Natural Training — 12–16 Weeks (Resistance Training Naïve Men)
| Metric | Before | After 12–16 Weeks |
| Lean Body Mass | Baseline | +2–4 kg (beginner gains) |
| 1RM Bench Press | Baseline | +25–40% typical increase |
| Serum Testosterone | ~450 ng/dL avg (untrained) | ↑ 15–25% with full optimization |
| IGF-1 | Baseline | ↑ 10–20% from training stimulus |
| MPS Rate | Resting baseline | ↑ 50–100% acutely post-workout |
AAS-Assisted — Testosterone 600 mg/week × 10–16 Weeks (Bhasin et al., NEJM 1996 RCT)
| Metric | Pre-Cycle | Post-Cycle |
| Lean Body Mass | Baseline | +6.1 kg (exercise + testosterone group) |
| Total Testosterone | 400–600 ng/dL | 3,000–5,000+ ng/dL |
| Nitrogen Retention | Balanced (natural) | Significantly positive (anabolic state) |
| Satellite Cell Count | Baseline | ↑ 44% (Kadi et al., 2000) |
| Muscle Fiber CSA (cross-section) | Baseline | ↑ 14–36% (Type I and II fibers) |
MK-677 Oral GH Secretagogue — 12 Months (Nass et al., 2008 RCT)
| Metric | Pre-Treatment | After 12 Months (25 mg/day) |
| IGF-1 | Baseline | ↑ 39–89% from baseline |
| Lean Body Mass | Baseline | +1.6–3.0 kg vs. placebo |
| GH Secretion | Age-related decline | Restored to youthful pulsatility levels |
- Bhasin S, et al. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. NEJM, 335(1), 1–7. https://doi.org/10.1056/NEJM199607043350101
- Schoenfeld BJ. (2010). The mechanisms of muscle hypertrophy and their application to resistance training. J Strength Cond Res, 24(10), 2857–2872. https://doi.org/10.1519/JSC.0b013e3181e840f3
- Schoenfeld BJ, et al. (2017). Dose-response relationship between weekly resistance training volume and increases in muscle mass. J Sports Sciences, 35(11), 1073–1082. https://doi.org/10.1080/02640414.2016.1210197
- Kraemer WJ, Ratamess NA. (2005). Hormonal responses and adaptations to resistance exercise and training. Sports Medicine, 35(4), 339–361. https://doi.org/10.2165/00007256-200535040-00004
- Morton RW, et al. (2018). A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength. BJSM, 52(6), 376–384. https://doi.org/10.1136/bjsports-2017-097608
- Leproult R, Van Cauter E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173–2174. https://doi.org/10.1001/jama.2011.710
- Pilz S, et al. (2011). Effect of vitamin D supplementation on testosterone levels in men. Hormone and Metabolic Research, 43(3), 223–225. https://doi.org/10.1055/s-0030-1269854
- Prasad AS, et al. (1996). Zinc status and serum testosterone levels of healthy adults. Nutrition, 12(5), 344–348. https://doi.org/10.1016/s0899-9007(96)80058-x
- Wankhede S, et al. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery. J Int Soc Sports Nutr, 12(1), 43. https://doi.org/10.1186/s12970-015-0104-9
- Tambi MI, et al. (2012). Standardised water-soluble extract of Eurycoma longifolia raises testosterone in men. Andrologia, 44(S1), 226–230. https://doi.org/10.1111/j.1439-0272.2011.01168.x
- Naghii MR, et al. (2011). Comparative effects of daily and weekly boron supplementation on plasma steroid hormones. J Trace Elements Med Biol, 25(1), 54–58. https://doi.org/10.1016/j.jtemb.2010.10.001
- Chapman IM, et al. (1996). Stimulation of the GH–IGF-I axis by daily oral administration of a GH secretagogue (MK-677). J Clin Endocrinol Metab, 81(12), 4249–4257. https://doi.org/10.1210/jcem.81.12.8954023
- Nass R, et al. (2008). Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Ann Intern Med, 149(9), 601–611. https://doi.org/10.7326/0003-4819-149-9-200811040-00003
- Van der Merwe J, et al. (2009). Three weeks of creatine monohydrate supplementation affects DHT:T ratio in college-aged rugby players. Clin J Sport Med, 19(5), 399–404. https://doi.org/10.1097/JSM.0b013e3181b8b52f
- Kadi F, et al. (2000). The effects of heavy resistance training and detraining on satellite cells in human skeletal muscles. J Physiology, 523(Pt 1), 13–16. https://doi.org/10.1111/j.1469-7793.2000.00013.x
- Schoenfeld BJ, et al. (2016). Effects of resistance training frequency on measures of muscle hypertrophy: A systematic review and meta-analysis. Sports Medicine, 46(11), 1689–1697. https://doi.org/10.1007/s40279-016-0543-8
- AI Generated?
- This content was created with the assistance of generative AI.